Management of antiplatelet therapy in patients with coronary stents undergoing noncardiac surgery

In clinical practice, significant variability exists with regards to the timing of elective noncardiac surgery after percutaneous coronary intervention (PCI) and the perioperative management of antiplatelet therapy.1 Although coronary revascularization should not be performed with the intent to reduce perioperative risks of noncardiac surgery, 2 up to 20% of the patients who have undergone PCI undergo noncardiac surgery within 2 years; 3.5% to 7.5% of these surgeries occur within 6 months of PCI.
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Commentary Source Type: research